Company news
Puretech Health Plc (LSE:PRTC) news
Puretech Health Plc news releases on 6ix. Latest, Apr 22, 2020: Akili ADHD Treatment Now Available in US
Press releases — page 7
Akili ADHD Treatment Now Available in US
April 22, 2020
PRTC to Present at Virtual Needham Conference
April 14, 2020
Gelesis: World's Most Innovative Companies List
March 10, 2020
Clinical Trial Initiated Of Wholly-Owned Candidate
March 3, 2020
Akili ADHD Study in The Lancet Digital Health
February 25, 2020
PureTech Receives $200M from KRTX Shares
January 23, 2020
Akili's New ADHD Trial Met Primary Endpoint
January 15, 2020
Follica Positive Androgenetic Alopecia Study
December 19, 2019
Gelesis Partners with US Telehealth Provider
December 17, 2019
Akili Meets Primary Endpoint in MDD Clinical Trial
December 12, 2019
Vedanta & BMS Begin Immuno-Oncology Clinical Study
December 10, 2019
Gelesis Attracts $84M in New Capital for Launch
December 9, 2019
Vedanta MultiDrug Resistance Program Granted $5.8M
December 5, 2019
Karuna Prices $250M Follow-On Offering
November 21, 2019
Karuna Successful Ph2 Schizophrenia Study Readout
November 18, 2019
resTORbio Update on Phase 3 Trial
November 15, 2019
PureTech to Present at Jefferies London Conference
November 13, 2019
PRTC Presents Novel Oncology Program Data at SITC
November 5, 2019
Sonde Names Healthcare Tech Exec David Liu as CEO
October 24, 2019
Minority Stake Acquisition & PDMR Notification
October 2, 2019
Vor Appoints Senior Cell & Gene Therapy Leaders
October 1, 2019
Vedanta Expands Series C with $62.1M Total Raised
September 23, 2019
PureTech Health plc Half-Year Report
August 27, 2019
Vor Names Biotech Vet Robert Ang President & CEO
August 7, 2019
Vor Biopharma Adds R&D Leader Bill Lundberg to BOD
July 31, 2019
PRTC Acquires Clinical Stage Asset for Lymphedema
July 17, 2019
Potential US Listing of PureTech Health on Nasdaq
July 11, 2019
PRTC Immuno-Oncology Programme Granted US Patent
July 9, 2019
PRTC's Karuna closes IPO, gross proceeds $102.6M
July 3, 2019
First Patient in Vedanta Food Allergy Study
July 1, 2019
PureTech's Karuna successfully lists on NASDAQ
June 28, 2019
PureTech Announces New Corporate HQ/Internal Labs
June 20, 2019
Follica Positive Interim Data & Plans for Pivotal
June 13, 2019
PRTC's Karuna Files Public S1 for NASDAQ IPO
June 3, 2019
PRTC to Present at Jefferies US Conference
May 30, 2019
Vor Publishes POC Study in Scientific Journal
May 29, 2019
Vedanta Presents Expanded Data from Successful Ph1
May 21, 2019
Promising Gelesis Data in Chronic Constipation
May 20, 2019
Gelesis & Vedanta Data at Digestive Disease Week
May 14, 2019
Vedanta Grows Series C Financing to $45.5 Million
May 13, 2019
Vedanta Prevails in Important EU Patent Opposition
May 7, 2019
PRTC's Karuna Files IPO Registration Statement
April 26, 2019
Gelesis Gets $10.6M Grant to Support Manufacturing
April 25, 2019
Boehringer Ingelheim & PRTC Immuno-oncology Collab
April 17, 2019
Gelesis Receives FDA Clearance for First Product
April 15, 2019
Akili Makes CFO & General Counsel Appointments
April 11, 2019
PRTC Presents Immuno-Oncology Programmes at AACR
April 2, 2019
Karuna expands Series B financing to $80 million
April 1, 2019
Gelesis New Clinical Data on Impact of Gelesis100
March 25, 2019
Gelesis to Present at Endocrine Society Annual Mtg
March 21, 2019